Reduced IFNL1 and/or IFNL2, but not IFNL3 is associated with worse outcome in patients with COVID-19.
Woods E, Mena A, Sierpinska S, Carr E, Sttar Bioresource, Hagan R, Crowley J, Bergin C, Clark D, Brophy C, Macallan D, Gardiner CM.
Woods E, et al. Among authors: gardiner cm.
Clin Exp Immunol. 2024 Nov 12;218(3):300-307. doi: 10.1093/cei/uxae047.
Clin Exp Immunol. 2024.
PMID: 38953458
Free PMC article.